FUJIFILM Corporation supports pharmaceutical and biotechnology R&D teams with technologies and services designed to accelerate drug discovery and reduce preclinical risk. Drawing on expertise across life sciences, chemistry, AI, and engineering, Fujifilm combines experimental science with advanced modeling to help researchers make faster, more informed development decisions.
Its capabilities include peptide discovery using mRNA display technology, iPSC-based drug discovery platforms, advanced data modeling and AI-enabled compound simulation, as well as access to specialized reagents, media, and broader CDMO capabilities. Fujifilm works with research teams to develop customized solutions across discovery, modeling, and analysis, supporting the progression of new therapeutic candidates toward the clinic.
